Effect of Comprehensive Health Management on Medication Adherence and Healthy Lifestyle Behavior of Patients With Hypertension
International Journal of Hypertension · 2025-01 · 2025 (1)
DOI: 10.1155/ijhy/1165809 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hypertension, online erschienen am 19.07.2025. Verfasst von Xinyuan Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Public Health Safety Ministry of Education, National Health Commission Key Laboratory of Health Technology Assessment, School of Pu…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Suboptimal medication adherence and unhealthy lifestyle behaviors are well‐recognized contributing factors to poor blood pressure control in hypertension patients. We evaluated the effectiveness of comprehensive health management in improving medication adherence and promoting healthy lifestyle behaviors among hypertension patients in China. A cluster randomized trial was implemented in rural areas of three provinces of China. Participants were individuals aged ≥ 40 years with uncontrolled hypertension. The intervention group received multidimensional health management measures codeveloped by healthcare organizations, village doctors, and patients, while the control group received standard care. The coprimary outcomes included the proportion of patients demonstrating good medication adherence and adherence to ≥ 3 healthy lifestyle components. Secondary outcomes comprised the proportion achieving controlled hypertension (BP < 140/90 mm Hg). From May 8th to November 28th, 2018, 9204 participants were enrolled. At 18‐month follow‐up, significantly higher medication adherence was observed in the intervention group compared with the control group, with an absolute difference of 5.0% (95% confidence interval (CI): 2.8–7.2; p < 0.001). Similarly, adherence to ≥ 3 healthy lifestyles was achieved by 45.8% in the intervention group versus 33.7% in controls, yielding a 12.1% between‐group difference (95% CI: 9.9–14.3; p < 0.001). Hypertension control rates differed significantly between groups (43.2% vs. 23.9%; absolute difference 19.2% and 95% CI: 17.2–21.3; p < 0.001). Hypertension patients receiving comprehensive health management in rural China demonstrated superior medication adherence and healthier lifestyle behaviors compared with those receiving standard care over 18 months. Further investigations are warranted to evaluate the cost‐effectiveness and generalizability of this intervention. Trial Registration: ClinicalTrials.gov identifier: NCT03527719
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Public Health Safety Ministry of Education, National Health Commission Key Laboratory of Health Technology Assessment, School of Public Health, Fudan University, Shanghai, China.
ORCID-Profile: Xinyuan Lu, Jiwei Wang, Sikun Chen, Lin Lv, Jinming Yu
Förderung
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Lu, X., Wang, J., Chen, S., Lv, L., & Yu, J. (2025). Effect of Comprehensive Health Management on Medication Adherence and Healthy Lifestyle Behavior of Patients With Hypertension. International Journal of Hypertension, 2025(1). https://doi.org/10.1155/ijhy/1165809
Vancouver
Lu X, Wang J, Chen S, Lv L, Yu J. Effect of Comprehensive Health Management on Medication Adherence and Healthy Lifestyle Behavior of Patients With Hypertension. International Journal of Hypertension. 2025;2025(1). doi:10.1155/ijhy/1165809
BibTeX
@article{Lu2025,
author = {Lu, Xinyuan and Wang, Jiwei and Chen, Sikun and Lv, Lin and Yu, Jinming},
title = {Effect of Comprehensive Health Management on Medication Adherence and Healthy Lifestyle Behavior of Patients With Hypertension},
journal = {International Journal of Hypertension},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/ijhy/1165809}
}
EUVIMED